Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by PBaelishhon Jan 15, 2024 5:10pm
73 Views
Post# 35827832

RE:RE:The question is what happens....

RE:RE:The question is what happens.......and COVID gave Gagnon a tool that enables his incompetence, allowing him to avoid accountability.

Per the Globe and Mail article:
"Securities regulators sit idle as companies use virtual meetings to silence shareholders"
Globe Article

Excerpt:
A lack of regulation concerning how virtual shareholder meetings are run has created a deep deficit in the ability to enforce rules of order and process at a basic level. The current format of virtual meetings impedes shareholder participation in the affairs of Canadian public companies. The critical dialogue between issuers and investors that makes companies better is being stifled. Canadian securities regulators can fix this, but they need to act decisively.

Methinks both AEZS shareholders and, more importantly, US & Canadian regulators should be made aware of Gagnon's playbook. 
<< Previous
Bullboard Posts
Next >>